World

U.S. Senate confirms hedge fund manager Scott Bessent as Treasury Secretary

Jan 28, 2025

Washington DC [US], January 28: The U.S. Senate on Monday confirmed hedge fund manager Scott Bessent as Treasury Secretary, positioning him to lead the new administration's economic policies, including tariffs, tax cuts and deregulation.
The upper chamber approved the nomination by a vote of 68 to 29.
Born in Conway, South Carolina, Bessent is the founder and CEO of Key Square Group, a global macro investment firm. He previously stated that, if confirmed, he would resign from the firm and divest his assets to prevent any conflicts of interest.
Bessent faced scrutiny from Democrats on the Senate Finance Committee after Democratic staff reviewed his tax returns, revealing that he had structured his hedge fund earnings to avoid over 900,000 in payroll taxes. Bessent defended his actions, stating that he had followed all relevant tax laws.
The confirmation marks another quick approval of President Donald Trump's cabinet picks, with the Senate already confirming several key positions just a month into the administration.
On Saturday, the Senate confirmed South Dakota Governor Kristi Noem as Secretary of Homeland Security, tasking her with enforcing the administration's stricter immigration policies.
Other recent confirmations include Marco Rubio as Secretary of State, John Ratcliffe as Central Intelligence Agency (CIA) Director, and Pete Hegseth as Secretary of Defense.
Source: Xinhua News Agency

More news

Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial

Tampa (Florida) [US], November 2: Sirolimus-coated balloon (SCB) strategy was non-inferior to contemporary everolimus-eluting stents (EES) for Target Lesion Failure (TLF) at 12 months in patients with de novo coronary artery disease. These are the results of the TRANSFORM II randomised trial, presented today as a Late-Breaking Clinical Trial at TCT 2026 and accepted in The Lancet which confirm how MagicTouch Sirolimus Coated Balloon (Concept Medical) matches contemporary best in class stent. Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease.

Nov 02, 2026